4035.0 Public Health Response to Personalized Medicine

Tuesday, October 30, 2012: 8:30 AM - 10:00 AM
Oral
The use of personalized medicine to diagnose and provide personalized, genomic-based therapies for diseases poses unique scientific, ethical, clinical, and policy opportunities and challenges for public health. There is a need to identify the areas of most benefit and potential challenge to public health. Speakers in this session will present work that overviews the areas of most need to address, including privacy and confidentiality of genetic information, informed decision making around genetic technology and information, and gene patenting. Other speakers will focus on particular health areas pertinent to public health and present research on the utility of genomic information in assessing risk for cardiovascular conditions and asthma, among others.
Session Objectives: Assess the opportunities and benefits of genomic technologies for conditions of public health importance.
Moderator:
Peter Tonellato, PhD

8:30am
Getting Personal – Scientific, Ethical, Public Health, and Policy Implications on Integrating Personalized Medicine into the Public's Health
Nelson Atehortua, PhD MPH, David Perlman, PhD and Amalia M. Issa, PhD, MPH
8:50am
Examining the Clinical Utility of Genomic Testing for Cardiovascular Disease Risk
Danielle Soucier, MBE and Barbara Bernhardt, MS, CGC
     
9:10am
Community role for implementation of expanding recommended uniform newborn screening panel
Sylvia M. Au, MS
     

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Genomics Forum

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH) , Masters Certified Health Education Specialist (MCHES)

See more of: Genomics Forum
<< Previous Session | Next Session >>